Table 1.
Demographic and clinical characteristics of all included study patients
| Patients characteristics | |
|---|---|
| Number of patients | 111 |
| Male/Female, n (%) | 68/43 (61/39) |
| Age, years (mean ± SD) | M 68 ± 16, F 68 ± 14 |
| Bleeding Site | |
| Upper GI-bleeding, n (%) | 78 (70) |
| Oesophagus | 10 (9) |
| Stomach | 31 (28) |
| Duodenum/Jejunum | 37 (33) |
| Lower GI-bleeding, n (%) | 33 (30) |
| Right colon | 15 (14) |
| Left colon | 18 (16) |
| Type of lesion, n (%) | |
| Peptic ulcer | 42 (38) |
| Post-polypectomy (EMR/ESD) | 28 (25) |
| Tumour | 15 (14) |
| Vascular lesions (angiectasia) | 6 (5) |
| Colon diverticula | 5 (4.5) |
| Mucosal lesions (e.g. Mallory-Weiss) | 2 (2) |
| Other* | 13 (12) |
| Bleeding Activity, n (%) | |
| Spurting haemorrhage | 7 (6) |
| Oozing haemorrhage | 76 (69) |
| Non-bleeding visible vessel | 16 (14) |
| Adherent clot | 6 (5) |
| Flat pigmented spot | 6 (5) |
SD standard deviation, DOAC direct oral anticoagulants, LMWH low molecular weight heparin, ASA acetylsalicylic acid, GI gastrointestinal, EMR endoscopic mucosal resection, ESD endoscopic submucosal dissection, PEG percutaneous endoscopic gastrostomy
*Post-papillotomy, post-biopsy, percutaneous endoscopic gastrostomy (PEG) complication, anastomosis